These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 33070079)

  • 41. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries.
    Marian AJ
    Cardiovasc Pathol; 2021; 50():107278. PubMed ID: 32889088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.
    Tandon S; Aggarwal A; Jain S; Shukla S; Chaudhary S
    Protein J; 2020 Dec; 39(6):631-643. PubMed ID: 33034824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    Hosoki K; Chakraborty A; Sur S
    J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine.
    Guan W; Lan W; Zhang J; Zhao S; Ou J; Wu X; Yan Y; Wu J; Zhang Q
    Virol Sin; 2020 Dec; 35(6):685-698. PubMed ID: 32997322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review.
    Khani E; Khiali S; Entezari-Maleki T
    J Clin Pharmacol; 2021 Apr; 61(4):429-460. PubMed ID: 33511638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARS-CoV-2: vaccines in the pandemic era.
    Li DD; Li QH
    Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies.
    Li CX; Noreen S; Zhang LX; Saeed M; Wu PF; Ijaz M; Dai DF; Maqbool I; Madni A; Akram F; Naveed M; Li JH
    Biomed Pharmacother; 2022 Feb; 146():112550. PubMed ID: 34959116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
    Goel B; Bhardwaj N; Tripathi N; Jain SK
    Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronavirus pandemic: treatment and future prevention.
    Lundstrom K
    Future Microbiol; 2020 Oct; 15(15):1507-1521. PubMed ID: 33140657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.
    Wang MY; Zhao R; Gao LJ; Gao XF; Wang DP; Cao JM
    Front Cell Infect Microbiol; 2020; 10():587269. PubMed ID: 33324574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging treatment strategies for COVID-19 infection.
    Gavriatopoulou M; Ntanasis-Stathopoulos I; Korompoki E; Fotiou D; Migkou M; Tzanninis IG; Psaltopoulou T; Kastritis E; Terpos E; Dimopoulos MA
    Clin Exp Med; 2021 May; 21(2):167-179. PubMed ID: 33128197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.
    Shahverdi M; Darvish M
    Curr Mol Med; 2021; 21(7):562-572. PubMed ID: 33272178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
    Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of high-resolution structural data on stemming the COVID-19 pandemic.
    Cox RM; Plemper RK
    Curr Opin Virol; 2021 Aug; 49():127-138. PubMed ID: 34130040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.
    Amawi H; Abu Deiab GI; A Aljabali AA; Dua K; Tambuwala MM
    Ther Deliv; 2020 Apr; 11(4):245-268. PubMed ID: 32397911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.